E2 Achieves Dual FDA Clearances for Innovative Hēlo® Platform to Combat Pulmonary Embolism #United_States #Menlo_Park #Endovascular_Engineering #Hēlo_Thrombectomy #PE_Treatment
@newsen.bsky.social@newsen.bsky.social
@newsen.bsky.socialE2 Achieves Dual FDA Clearances for Innovative Hēlo® Platform to Combat Pulmonary Embolism #United_States #Menlo_Park #Endovascular_Engineering #Hēlo_Thrombectomy #PE_Treatment